Company news

Biodesix, Inc. news in 2021

Biodesix, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Biodesix Announces Appointment of Successful Innovator and Scientific Professional Jon Faiz Kayyem, PhD to Board of Directors

December 7, 2021

Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer

November 30, 2021

Biodesix Announces Publication Highlighting Interim Data from the INSIGHT Study Assessing the Clinical Effectiveness of VeriStrat® Proteomic Test in the Journal of Immunotherapy of Cancer

November 17, 2021

Biodesix Announces Third Quarter 2021 Results and Highlights

November 14, 2021

Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021

October 31, 2021

Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting

October 12, 2021

Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer

September 15, 2021

Biodesix DeSoto Laboratory Receives both ISO 13485: 2016 Certification and Accreditation from the College of American Pathologists

August 24, 2021

Biodesix Announces Second Quarter 2021 Results and Highlights

August 9, 2021

Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021

July 26, 2021

Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test

June 14, 2021

Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank

June 3, 2021

Biodesix Announces First Quarter 2021 Results

May 10, 2021

Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround Time

April 27, 2021

Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021

April 25, 2021

Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch Plans

April 25, 2021

Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management

April 21, 2021

Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients

April 9, 2021

Biodesix Announces Issuance of Two U.S. Patents, Expands Coverage of Diagnostic Methods to Improve Care for Cancer Patients

April 5, 2021

Biodesix Announces Closing of New $30 Million Term Loan

March 22, 2021

Biodesix Announces Fourth Quarter and Full Year 2020 Results

March 15, 2021

Biodesix to Report Fourth Quarter and Fiscal 2020 Financial Results on March 16, 2021

March 8, 2021

Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools

February 15, 2021

Biodesix Anticipates Strong Preliminary Fourth Quarter 2020 Revenue (unaudited)

January 7, 2021

Biodesix Announces Hiring of Ryan Siurek as Chief Accounting Officer

January 4, 2021

Calls in 2021

Decks in 2021